Scarica l'app Stockscreener
14.35
2.05%
-0.30
Dopo l'orario di chiusura:
14.35
Precedente Chiudi:
$14.65
Aprire:
$14.6
Volume 24 ore:
670.51K
Relative Volume:
0.87
Capitalizzazione di mercato:
$1.51B
Reddito:
-
Utile/perdita netta:
$-150.70M
Rapporto P/E:
-9.2581
EPS:
-1.55
Flusso di cassa netto:
$-125.67M
1 W Prestazione:
-3.37%
1M Prestazione:
+2.87%
6M Prestazione:
-45.62%
1 anno Prestazione:
-22.10%
Intervallo 1D:
$14.12
$14.70
Intervallo di 1 settimana:
$13.93
$14.94
Portata 52W:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Nome
Edgewise Therapeutics Inc
Settore
Industria
Telefono
720-262-7002
Indirizzo
1715 38TH ST, BOULDER
Confronta EWTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
14.35 | 1.54B | 0 | -150.70M | -125.67M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-30 | Iniziato | Raymond James | Strong Buy |
| 2025-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-30 | Iniziato | Guggenheim | Buy |
| 2025-04-02 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-01-22 | Iniziato | Stifel | Hold |
| 2024-11-22 | Iniziato | Evercore ISI | Outperform |
| 2024-03-07 | Iniziato | Piper Sandler | Overweight |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2022-08-25 | Downgrade | Goldman | Neutral → Sell |
| 2022-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-01-28 | Iniziato | Goldman | Neutral |
Mostra tutto
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Edgewise Therapeutics, Inc. $EWTX Shares Acquired by Siren L.L.C. - MarketBeat
Regression analysis insights on Edgewise Therapeutics Inc. performancePortfolio Risk Report & Smart Swing Trading Alerts - Newser
Will Edgewise Therapeutics Inc. stock go up soon2025 Top Gainers & Smart Investment Allocation Tips - Newser
Nuveen LLC Acquires Shares of 202,580 Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Analyzing drawdowns of Edgewise Therapeutics Inc. with statistical tools2025 Biggest Moves & Safe Swing Trade Setups - Newser
What moving averages say about Edgewise Therapeutics Inc.Buy Signal & Reliable Volume Spike Trade Alerts - Newser
What’s the recovery path for long term holders of Edgewise Therapeutics Inc.Breakout Watch & Precise Swing Trade Entry Alerts - Newser
Volume spikes in Edgewise Therapeutics Inc. stock – what they meanTrade Exit Summary & Safe Capital Growth Tips - Newser
Published on: 2025-08-30 20:31:50 - Newser
Will breakout in Edgewise Therapeutics Inc. lead to full recoveryMarket Rally & Free Risk Controlled Daily Trade Plans - Newser
What earnings revisions data tells us about Edgewise Therapeutics Inc.Weekly Market Report & AI Optimized Trade Strategies - Newser
Edgewise Therapeutics Inc. stock chart pattern explainedTrade Analysis Report & Risk Controlled Daily Trade Plans - Newser
Is Edgewise Therapeutics Inc. stock poised for growthQuarterly Portfolio Summary & Daily Entry Point Alerts - Newser
Chart based exit strategy for Edgewise Therapeutics Inc.IPO Watch & Expert Curated Trade Ideas - Newser
Published on: 2025-08-29 19:13:04 - Newser
How Edgewise Therapeutics Inc. stock performs during market volatilityM&A Rumor & Safe Swing Trade Setups - Newser
Can trapped investors hope for a rebound in Edgewise Therapeutics Inc.July 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
Quantitative breakdown of Edgewise Therapeutics Inc. recent moveEarnings Beat & Precise Buy Zone Identification - Newser
Brokerages Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) PT at $40.55 - MarketBeat
Published on: 2025-08-29 15:50:13 - Newser
What is the target price for Edgewise Therapeutics Inc. stockPortfolio Growth Summary & High Win Rate Trade Tips - sundaytimes.kr
Sentiment analysis tools applied to Edgewise Therapeutics Inc.2025 Price Action Summary & Weekly Stock Performance Updates - Newser
How to build a dashboard for Edgewise Therapeutics Inc. stockPortfolio Profit Report & Community Supported Trade Ideas - Newser
Intraday pattern recognizer results for Edgewise Therapeutics Inc.July 2025 Decliners & Momentum Based Trading Signals - Newser
Published on: 2025-08-29 11:38:03 - Newser
Applying Wyckoff theory to Edgewise Therapeutics Inc. stockJuly 2025 Technicals & Fast Moving Trade Plans - Newser
Edgewise Therapeutics Insider Makes Major Stock Sale Amid Q2 Earnings Report and Analyst Coverage - AInvest
Edgewise Therapeutics Inc. Approaches Support With Recovery in Sight getLinesFromResByArray error: size == 0 - newsyoung.net
Edgewise Therapeutics, Inc. $EWTX Holdings Reduced by Vanguard Group Inc. - MarketBeat
Candriam S.C.A. Has $4.97 Million Stock Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):